Aripiprazole

Aripiprazole (CAS 129722-12-9), supplied by Polpharma, is manufactured directly as an injection-grade anhydrous API in the Type I polymorphic form across two dedicated in-house commercial production lines, meeting USP and EP standards. It is an antipsychotic used to treat schizophrenia, Tourette's disorder and autism-related symptoms in children, bipolar I disorder, and as an adjunct in major depressive disorder, distributed globally with samples available; note that in Poland, patent-protected forms are offered only for regulatory/R&D submission purposes, not commercial sale.